Dynorphin B

From Wikipedia, the free encyclopedia
Dynorphin B[1]
Dynorphin B.svg
Names
Other names
Dynorphin B-13; Rimorphin
Identifiers
CAS Number
  • 85006-82-2 checkY
3D model (JSmol)
ChemSpider
PubChem CID
CompTox Dashboard (EPA)
InChI
SMILES
Properties
Chemical formula
C74H115N21O17
Molar mass 1570.8354
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N  (what is checkY☒N ?)
Infobox references

Dynorphin B, also known as rimorphin,[2] is a form of dynorphin and an endogenous opioid peptide with the amino acid sequence Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr. Dynorphin B is generated as a proteolytic cleavage product of leumorphin, which in turn is a cleavage product of preproenkephalin B (prodynorphin).[citation needed]


Dynorphin B has an identical N-terminal sequence, but different C-terminal sequence to Dynorphin A. In an alanine scan of the non-glycine residues of dynorphin B, it was discovered that Tyr1 and Phe4 residues are critical for both opioid receptor affinity and κ-opioid receptor agonist potency, Arg6 and Arg7 promote κ-opioid affinity and Lys10 contributes to the opioid receptor affinity.[3]

Inducers of Dynorphin B[]

Cannabinoid CP55,940 and △9-tetrahydrocannabinol (△9-THC) can induce the release of dynorphin B, which in return acts as an agonist of κ-opioid receptors, resulting in the production of antinociception.[4] Similarly, Tyr-D-Arg-Phe-Sar (TAPS) is capable of promoting a release of dynorphin B through the simulation of μ1-opioid receptors, causing a production of antinociception.[5] The antinociceptive effect produced by dynorphin B allows for spinal analgesia.

See also[]

References[]

  1. ^ Dynorphin B - Compound Summary, PubChem.
  2. ^ Paul V. Malven (12 January 1993). Mammalian Neuroendocrinology. CRC Press. p. 70. ISBN 978-0-8493-8757-9. Retrieved 22 April 2012.
  3. ^ Joshi, Anand A.; Murray, Thomas F.; Aldrich, Jane V. (September 2017). "Alanine scan of the opioid peptide dynorphin B amide". Biopolymers. 108 (5): e23026. doi:10.1002/bip.23026. PMC 6003702. PMID 28464209.
  4. ^ Houser, Susan J; Eads, Micah; Embrey, James P; Welch, Sandra P (February 2000). "Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Δ9-THC and anandamide1Published on the World Wide Web on 18 January 2000.1". Brain Research. 857 (1–2): 337–342. doi:10.1016/S0006-8993(00)01981-8. PMID 10700588. S2CID 8616013.
  5. ^ Mizoguchi, Hirokazu; Ito, Kanenori; Watanabe, Hiroyuki; Watanabe, Chizuko; Katsuyama, Sou; Fujimura, Tsutomu; Sakurada, Tsukasa; Sakurada, Shinobu (November 2006). "Contribution of spinal μ1-opioid receptors and dynorphin B to the antinociception induced by Tyr-d-Arg-Phe-Sar". Peptides. 27 (11): 2786–2793. doi:10.1016/j.peptides.2006.07.006. PMID 16919848. S2CID 1770295.



Retrieved from ""